Next Article in Journal
Evaluation of Dried Blood Spot Testing for SARS-CoV-2 Serology Using a Quantitative Commercial Assay
Next Article in Special Issue
The Spike of Concern—The Novel Variants of SARS-CoV-2
Previous Article in Journal
Anti-SARS-CoV-2 Activity of Surgical Masks Infused with Quaternary Ammonium Salts
Previous Article in Special Issue
SARS-CoV-2 Disinfection of Air and Surface Contamination by TiO2 Photocatalyst-Mediated Damage to Viral Morphology, RNA, and Protein
Opinion

Repeated Exposure to Subinfectious Doses of SARS-CoV-2 May Promote T Cell Immunity and Protection against Severe COVID-19

1
Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità (National Institute of Health), 00161 Rome, Italy
2
Environment and Health Department, Istituto Superiore di Sanità, 00161 Rome, Italy
3
Department of Medicine and Translational Surgery, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
4
Institute of General Pathology, Policlinico Universitario Fondazione A. Gemelli, 00168 Rome, Italy
*
Author to whom correspondence should be addressed.
The first two authors contributed equally to the manuscript.
The last two authors contributed equally to the manuscript.
Academic Editors: Luis Martinez-Sobrido and Fernando Almazan Toral
Viruses 2021, 13(6), 961; https://doi.org/10.3390/v13060961
Received: 2 April 2021 / Revised: 14 May 2021 / Accepted: 19 May 2021 / Published: 22 May 2021
(This article belongs to the Collection SARS-CoV-2 and COVID-19)
Europe is experiencing a third wave of COVID-19 due to the spread of highly transmissible SARS-CoV-2 variants. A number of positive and negative factors constantly shape the rates of COVID-19 infections, hospitalization, and mortality. Among these factors, the rise in increasingly transmissible variants on one side and the effect of vaccinations on the other side create a picture deeply different from that of the first pandemic wave. Starting from the observation that in several European countries the number of COVID-19 infections in the second and third pandemic wave increased without a proportional rise in disease severity and mortality, we hypothesize the existence of an additional factor influencing SARS-CoV-2 dynamics. This factor consists of an immune defence against severe COVID-19, provided by SARS-CoV-2-specific T cells progressively developing upon natural exposure to low virus doses present in populated environments. As suggested by recent studies, low-dose viral particles entering the respiratory and intestinal tracts may be able to induce T cell memory in the absence of inflammation, potentially resulting in different degrees of immunization. In this scenario, non-pharmaceutical interventions would play a double role, one in the short term by reducing the detrimental spreading of SARS-CoV-2 particles, and one in the long term by allowing the development of a widespread (although heterogeneous and uncontrollable) form of immune protection. View Full-Text
Keywords: COVID-19; SARS-CoV-2; protective immunity; T cell responses; facial masking; fomites; environmental exposure; memory T cells COVID-19; SARS-CoV-2; protective immunity; T cell responses; facial masking; fomites; environmental exposure; memory T cells
Show Figures

Figure 1

MDPI and ACS Style

De Angelis, M.L.; Francescangeli, F.; Rossi, R.; Giuliani, A.; De Maria, R.; Zeuner, A. Repeated Exposure to Subinfectious Doses of SARS-CoV-2 May Promote T Cell Immunity and Protection against Severe COVID-19. Viruses 2021, 13, 961. https://doi.org/10.3390/v13060961

AMA Style

De Angelis ML, Francescangeli F, Rossi R, Giuliani A, De Maria R, Zeuner A. Repeated Exposure to Subinfectious Doses of SARS-CoV-2 May Promote T Cell Immunity and Protection against Severe COVID-19. Viruses. 2021; 13(6):961. https://doi.org/10.3390/v13060961

Chicago/Turabian Style

De Angelis, Maria L., Federica Francescangeli, Rachele Rossi, Alessandro Giuliani, Ruggero De Maria, and Ann Zeuner. 2021. "Repeated Exposure to Subinfectious Doses of SARS-CoV-2 May Promote T Cell Immunity and Protection against Severe COVID-19" Viruses 13, no. 6: 961. https://doi.org/10.3390/v13060961

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop